To learn more about this report, Request sample copy
North America has been dominating the global Barrett’s esophagus market for past several years. The region accounts for over 34.5% share of the total market revenue owing to high prevalence of obesity, GERD and other risk factors associated with Barrett’s Esophagus in countries like U.S. Strong healthcare infrastructure and availability of advanced diagnosis and treatment options have enabled faster diagnosis and clinical management of patients in the region. Major market players have their headquarters in the region and focus on R&D to develop new drugs and devices. This has ensured early adoption of novel treatment options in North America.
The Asia Pacific region is emerging as the fastest growing market for Barrett’s esophagus currently. Countries like China, India and Japan are witnessing rapid economic development and improvement in healthcare access and quality of care. Rising healthcare expenditure, growing medical tourism and presence of generic drug manufacturers are driving growth. Further, growing obese population base and lifestyle changes making people prone to gastrointestinal disorders have widened the patient pool in the region. This has attracted many global industry players to tap into opportunities by establishing local manufacturing plants and distribution networks.
China alone contributes over one-third of the total Asia Pacific market value. This is majorly attributed to the country's huge population size whereby even lower prevalence of the disease translates into large number of patients. Rising disposable income is enabling people to opt for advanced diagnostic procedures and therapeutics. Both public and private healthcare sectors are expanding fast to cater the growing needs. This makes China one of the most promising markets offering high potential growth during the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients